Progress made toward understanding best non-invasive tests for NASH, fibrosis diagnosis

progress made toward understanding best non invasive tests for nash fibrosis diagnosis

Sumary of Progress made toward understanding best non-invasive tests for NASH, fibrosis diagnosis:

  • November 15, 2021 3 min read Source/Disclosures Published by: Source: Sanyal AJ.
  • receiving grant/research support from Allergan, Boehringer Ingelheim, Intercept, Inventiva, Bristol Myers, Cirius Therapeutics, Cumberland, Echosens, Galectin, Galmed, Gilead, Intercept, Karius, Madrigal, Mallinckrodt, Merck, Novartis, Pfizer, Salix, Second Genome, Sequana and Thera technologies;
  • Sanyal, MBBS, MD, professor in the department of internal medicine in the division of gastroenterology, hepatology and nutrition at Virginia Commonwealth University School of Medicine, said during The Liver Meeting Digital Experience.
  • Sanyal noted this subset of patients was the only one to have a FibroScan (Echosens) performed within the pre-set time period.

Want to know more click here go to source.

From -

Close

Site Language


Popular Posts

737

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close